Lipid transfers to HDL are predictors of precocious clinical coronary heart disease
Authors:
- Raul C. MaranhãoRMRaul C. Maranhão
- Fatima R. FreitasFFFatima R. Freitas
- Célia M. StrunzCSCélia M. Strunz
- Raul D. SantosRSRaul D. Santos
- Alfredo J. MansurAMAlfredo J. Mansur
- Antônio P. MansurAMAntônio P. Mansur
- 1 February 2012
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 413 (3-4) , 502-505
Abstract
No abstract availableKeywords
Funding Information
- Fundação do Amparo à Pesquisa do Estado de São Paulo (FAPESP), São Paulo, SP, Brazil
This publication has 24 references indexed in Scilit:
- Update on CETP inhibitionJournal of Clinical Lipidology, 2010
- Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activitiesCurrent Opinion in Lipidology, 2010
- HDL as a Biomarker, Potential Therapeutic Target, and TherapyDiabetes, 2009
- Transfer of Cholesterol and Other Lipids From a Lipid Nanoemulsion to High-density Lipoprotein in Heart Transplant PatientsThe Journal of Heart and Lung Transplantation, 2009
- In Vitro Simultaneous Transfer of Lipids to HDL in Coronary Artery Disease and in Statin TreatmentLipids, 2009
- Structural modifications of HDL and functional consequencesAtherosclerosis, 2006
- Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL CholesterolNew England Journal of Medicine, 2004
- The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides: a current reviewThe American Journal of Cardiology, 2000
- PLASMA LIPID TRANSFER PROTEINSAnnual Review of Biochemistry, 1995
- Metabolic behavior in rats of a nonprotein microemulsion resembling low‐density lipoproteinLipids, 1993